Rossano, JW, Jang, GY. Pediatric heart failure: current state and future possibilities. Korean Circ J
2015; 45: 1–8.
Fiuzat, M, O’Connor, CM, Gueyffier, F, et al. Biomarker-guided therapies in heart failure: a forum for unified strategies. J Card Fail
2013; 19: 592–599.
Gruson, D, Ahn, SA, Rousseau, MF. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure. Peptides
2015; 64: 24–28.
Cohen, S, Springer, C, Avital, A, et al. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress. Pediatrics
2005; 115: 1347–1350.
Nir, A, Bar-Oz, B, Perles, Z, Brooks, R, Korach, A, Rein, AJ. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr
2004; 93: 603–607.
Nir, A, Nasser, N. Clinical value of NT-proBNP and BNP in pediatric cardiology. J Card Fail
2005; 11: S76–S80.
Zhang, SR, Zhang, YH, Xu, Q, Qiu, HX, Chen, Q. Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with CHD. Zhongguo Dang Dai Er Ke Za Zhi
2009; 11: 429–432.
Bradham, DM, Igarashi, A, Potter, RL, Grotendorst, GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol
1991; 114: 1285–1294.
Chen, L, Charrier, A, Zhou, Y, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology
2014; 59: 1118–1129.
Klaassen, I, van Geest, RJ, Kuiper, EJ, van Noorden, CJ, Schlingemann, RO. The role of CTGF in diabetic retinopathy. Exp Eye Res
2015; 133: 37–48.
Wu, CK, Wang, YC, Lee, JK, et al. Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models. Eur J Heart Fail
2014; 16: 163–172.
Dziadzio, M, Usinger, W, Leask, A, et al. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM
2005; 98: 485–492.
Koitabashi, N, Arai, M, Niwano, K, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail
2008; 10: 373–379.
Bergestuen, DS, Gravning, J, Haugaa, KH, et al. Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer
2010; 10: 6.
Behnes, M, Brueckmann, M, Lang, S, et al. Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure. Clin Res Cardiol
2014; 103: 107–116.
Miyazaki, O, Kurashita, S, Fukamachi, I, Endo, K, Ng, PS, Takehara, K. Subtraction method for determination of N-terminal connective tissue growth factor. Ann Clin Biochem
2010; 47: 205–211.
Ross, RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol
2012; 33: 1295–1300.
Lopez, L, Colan, SD, Frommelt, PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr
2010; 23: 465–495; quiz 576–577.
Cicha, I, Garlichs, CD, Daniel, WG, Goppelt-Struebe, M. Activated human platelets release connective tissue growth factor. Thromb Haemost
2004; 91: 755–760.
Kato, M, Fujisawa, T, Hashimoto, D, et al. Plasma connective tissue growth factor levels as potential biomarkers of airway obstruction in patients with asthma. Ann Allergy Asthma Immunol
2014; 113: 295–300.
Hanley, JA, McNeil, BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology
1983; 148: 839–843.
Pencina, MJ, D’Agostino, RB Sr, D’Agostino, RB Jr, Vasan, RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med
2008; 27: 157–172; discussion 207–212.
Chuva de Sousa Lopes, SM, Feijen, A, Korving, J, et al. Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev Dyn
2004; 231: 542–550.
Ahmed, MS, Øie, E, Vinge, LE, et al. Connective tissue growth factor – a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol
2004; 36: 393–404.
Koitabashi, N, Arai, M, Kogure, S, et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension
2007; 49: 1120–1127.
Tsoutsman, T, Wang, X, Garchow, K, Riser, B, Twigg, S, Semsarian, C. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure. J Mol Cell Cardiol
2013; 62: 164–178.
Blom, IE, Goldschmeding, R, Leask, A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy. Matrix Biol
2002; 21: 473–482.
Sahin, M, Portakal, O, Karagöz, T, Hasçelik, G, Özkutlu, S. Diagnostic performance of BNP and NT-proBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin Biochem
2010; 43: 1278–1281.
Gravning, J, Ahmed, MS, von Lueder, TG, Edvardsen, T, Attramadal, H. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Int J Cardiol
2013; 168: 2049–2056.
Gravning, J, Ørn, S, Kaasbøll, OJ, et al. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction. PLoS One
2012; 7: e52120.
Braunwald, E. Biomarkers in heart failure. N Engl J Med
2008; 358: 2148–2159.
Hayata, N, Fujio, Y, Yamamoto, Y, et al. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun
2008; 370: 274–278.
Jungbauer, CG, Riedlinger, J, Block, D, et al. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure. Biomark Med
2014; 8: 777–789.
Bielecka-Dabrowa, A, Gluba-Brzózka, A, Michalska-Kasiczak, M, Misztal, M, Rysz, J, Banach, M. The multi-biomarker approach for heart failure in patients with hypertension. Int J Mol Sci
2015; 16: 10715–10733.